Leypoldt JK - Search Results

1

Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model.

Li L, Terry CM, Blumenthal DK, Kuji T, Masaki T, Kwan BC, Zhuplatov I, Leypoldt JK, Cheung AK. Li L, et al. Among authors: leypoldt jk. Nephrol Dial Transplant. 2007 Nov;22(11):3139-46. doi: 10.1093/ndt/gfm415. Epub 2007 Jun 30. Nephrol Dial Transplant. 2007. PMID: 17602194

2

Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis.

Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, Zhu W, Leypoldt JK, Rathi R, Blumenthal DK, Kern SE, Cheung AK. Kuji T, et al. Among authors: leypoldt jk. Kidney Int. 2006 Jun;69(12):2179-85. doi: 10.1038/sj.ki.5000383. Epub 2006 May 3. Kidney Int. 2006. PMID: 16672912 Free article.

3

Optimal use of hemodialyzers.

Leypoldt JK, Cheung AK. Leypoldt JK, et al. Contrib Nephrol. 2002;(137):129-37. doi: 10.1159/000060239. Contrib Nephrol. 2002. PMID: 12101945 No abstract available.

4

Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs.

Kim SJ, Masaki T, Leypoldt JK, Kamerath CD, Mohammad SF, Cheung AK. Kim SJ, et al. Among authors: leypoldt jk. J Lab Clin Med. 2004 Sep;144(3):156-62. doi: 10.1016/j.lab.2004.06.002. J Lab Clin Med. 2004. PMID: 15454885

5

Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel.

Masaki T, Rathi R, Zentner G, Leypoldt JK, Mohammad SF, Burns GL, Li L, Zhuplatov S, Chirananthavat T, Kim SJ, Kern S, Holman J, Kim SW, Cheung AK. Masaki T, et al. Among authors: leypoldt jk. Kidney Int. 2004 Nov;66(5):2061-9. doi: 10.1111/j.1523-1755.2004.00985.x. Kidney Int. 2004. PMID: 15496180 Free article.

6

Dialyzer membranes as determinants of the adequacy of dialysis.

Chelamcharla M, Leypoldt JK, Cheung AK. Chelamcharla M, et al. Among authors: leypoldt jk. Semin Nephrol. 2005 Mar;25(2):81-9. doi: 10.1016/j.semnephrol.2004.09.014. Semin Nephrol. 2005. PMID: 15791559

7

The association between BP and mortality in patients on chronic peritoneal dialysis.

Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. Goldfarb-Rumyantzev AS, et al. Among authors: leypoldt jk. Nephrol Dial Transplant. 2005 Aug;20(8):1693-701. doi: 10.1093/ndt/gfh856. Epub 2005 May 17. Nephrol Dial Transplant. 2005. PMID: 15899939

8

A crossover study of short daily haemodialysis.

Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung AK. Goldfarb-Rumyantzev AS, et al. Among authors: leypoldt jk. Nephrol Dial Transplant. 2006 Jan;21(1):166-75. doi: 10.1093/ndt/gfi116. Epub 2005 Sep 16. Nephrol Dial Transplant. 2006. PMID: 16169869 Clinical Trial.

9

Revisiting the hemodialysis dose.

Leypoldt JK, Cheung AK. Leypoldt JK, et al. Semin Dial. 2006 Mar-Apr;19(2):96-101. doi: 10.1111/j.1525-139X.2006.00132.x. Semin Dial. 2006. PMID: 16551284 Review.

10

Perivascular tissue pharmacokinetics of dipyridamole.

Goteti K, Masaki T, Kuji T, Leypoldt JK, Cheung AK, Kern SE. Goteti K, et al. Among authors: leypoldt jk. Pharm Res. 2006 Apr;23(4):718-28. doi: 10.1007/s11095-006-9746-2. Epub 2006 Mar 24. Pharm Res. 2006. PMID: 16552498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters